Compare Johnson Controls International PLC (JCI) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs Mesoblast Limited — how do they compare? Johnson Controls International PLC trades at $151.4 (market cap $92.55B), while Mesoblast Limited trades at $16.5 (market cap $2.20B). The key difference: Johnson Controls International PLC is far larger — about 42.1× Mesoblast Limited's market cap, and Johnson Controls International PLC pays a 1.05% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| JCI | MESO | |
|---|---|---|
Market Cap | $92.55B | $2.20B |
Sector | Industrials | Technology |
52-Week High | $154.76 | $20.96 |
52-Week Low | $103.52 | $12.88 |
Enterprise Value | $101.39B | $2.20B |
Dividend Yield | 1.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
